Holen Sie sich die Stockscreener-App
190.23
2.32%
4.32
Handel nachbörslich:
190.23
Schlusskurs vom Vortag:
$185.91
Offen:
$186.78
24-Stunden-Volumen:
1.56M
Relative Volume:
0.69
Marktkapitalisierung:
$32.34B
Einnahmen:
$15.50B
Nettoeinkommen (Verlust:
$1.33B
KGV:
25.92
EPS:
7.34
Netto-Cashflow:
$2.16B
1W Leistung:
+7.18%
1M Leistung:
+16.85%
6M Leistung:
-2.97%
1J Leistung:
-20.22%
1-Tages-Spanne:
$186.53
$190.81
1-Wochen-Bereich:
$176.72
$190.81
52-Wochen-Spanne:
$134.65
$252.88
Iqvia Holdings Inc Stock (IQV) Company Profile
Firmenname
Iqvia Holdings Inc
Sektor
Branche
Telefon
919-998-2000
Adresse
2400 ELLIS ROAD, DURHAM, NC
Vergleichen Sie IQV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
190.23 | 31.60B | 15.50B | 1.33B | 2.16B | 7.34 |
|
TMO
Thermo Fisher Scientific Inc
|
484.79 | 180.28B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
209.14 | 147.31B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
663.92 | 52.18B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
120.29 | 33.33B | 6.63B | 1.17B | 1.19B | 4.05 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-25 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-04-10 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-02-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-12-20 | Eingeleitet | Stephens | Overweight |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-09-04 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2024-06-06 | Eingeleitet | Goldman | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-15 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-02-13 | Eingeleitet | BTIG Research | Buy |
| 2023-11-02 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-03-17 | Eingeleitet | Truist | Buy |
| 2022-12-06 | Eingeleitet | Cowen | Outperform |
| 2022-11-17 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-15 | Eingeleitet | SVB Leerink | Outperform |
| 2022-05-24 | Eingeleitet | Guggenheim | Buy |
| 2022-04-29 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-16 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-03-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2020-07-07 | Eingeleitet | Stephens | Equal-Weight |
| 2020-03-02 | Eingeleitet | Deutsche Bank | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-12-13 | Hochstufung | CFRA | Sell → Hold |
| 2019-11-14 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-06-21 | Hochstufung | Mizuho | Neutral → Buy |
| 2019-05-28 | Eingeleitet | SVB Leerink | Outperform |
| 2019-01-18 | Hochstufung | Jefferies | Hold → Buy |
| 2018-10-09 | Eingeleitet | UBS | Buy |
| 2018-10-02 | Bestätigt | Robert W. Baird | Outperform |
| 2018-07-25 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-07-25 | Bestätigt | Stifel | Buy |
| 2018-07-03 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-04-13 | Hochstufung | Goldman | Neutral → Buy |
| 2018-03-07 | Hochstufung | SunTrust | Hold → Buy |
| 2018-01-19 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Iqvia Holdings Inc Aktie (IQV) Neueste Nachrichten
Fund Update: Clarkston Capital Partners, LLC added 237,975 shares of IQVIA HOLDINGS ($IQV) to their portfolio - Quiver Quantitative
IQVIA Holdings Forms Strategic Partnership with Kexing Biopharm to Enhance Global Drug Development Efforts - AInvest
IQVIA Holdings (IQV) Enters Partnership With Kexing Biopharm To Enhance Drug Development - uk.finance.yahoo.com
Kexing Biopharm enters strategic partnership with IQVIA - MarketScreener
What to Expect From IQVIA Holdings' Q2 2025 Earnings Report - MSN
Is IQVIA Holdings Inc. gaining market shareAggressive Growth Portfolio - thegnnews.com
Resistance Break Could Fuel IQVIA Holdings Inc. RallyShort Term Trading Opportunity Watch Sees Shift - beatles.ru
IQVIA Holdings Inc. Share Price Analysis: Growth and Valuation - AInvest
IQVIA Holdings Inc. Uptrend in Early Stages Indicators Say YesWeekly Watchlist of High Movers Released - beatles.ru
What are analysts’ price targets for IQVIA Holdings Inc. in the next 12 monthsAchieve fast wealth growth with smart picks - Jammu Links News
How does IQVIA Holdings Inc. compare to its industry peersUnstoppable investment returns - Jammu Links News
What is IQVIA Holdings Inc. company’s growth strategyHigh-yield capital appreciation - Jammu Links News
What are the technical indicators suggesting about IQVIA Holdings Inc.Discover high-growth stocks for your portfolio - Jammu Links News
Is IQVIA Holdings Inc. stock overvalued or undervaluedConsistently superior profits - Jammu Links News
What are IQVIA Holdings Inc. company’s key revenue driversFree Trend-Following Techniques - Jammu Links News
Why is IQVIA Holdings Inc. stock attracting strong analyst attentionExponentially increasing returns - Jammu Links News
What are the latest earnings results for IQVIA Holdings Inc.Capitalize on emerging market trends - Jammu Links News
What catalysts could drive IQVIA Holdings Inc. stock higher in 2025Unprecedented profit potential - Jammu Links News
What analysts say about IQVIA Holdings Inc. stockHigh-yield capital appreciation - Jammu Links News
IQVIA Holdings Inc. (NYSE:IQV) Position Boosted by CVA Family Office LLC - 富途牛牛
What markets is IQVIA Holdings Inc. expanding into Is SGLY stock a good long term investment optionRemarkably fast returns - Jammu Links News
Is IQVIA Holdings Inc. a growth stock or a value stockDiscover market opportunities with real-time data - Jammu Links News
What is the risk reward ratio of investing in IQVIA Holdings Inc. stockCapitalize on market trends with confidence - Jammu Links News
Is IQVIA Holdings Inc. a good long term investmentOutstanding investment returns - Jammu Links News
What is the dividend policy of IQVIA Holdings Inc. stockAdvanced Screener Ideas For Every Investor - jammulinksnews.com
IQVIA Holdings (NYSE:IQV) Sheds 4.7% This Week, as Yearly Returns Fall More in Line With Earnings Growth - 富途牛牛
IQVIA's 419th-Ranked Liquidity Amid Institutional Bullishness and Insider Selling Spree - AInvest
IQVIA’s Stock Lags While Long-Term Prospects Take Shape - Finimize
Understanding IQVIA Holdings' ROE: A Key to Unlocking Company Performance - AInvest
Why IQVIA Holdings Inc. (NYSE:IQV) Looks Like A Quality Company - Yahoo Finance
Verisk Earnings & Revenues Surpass Estimates in Q2, Increase Y/Y - The Globe and Mail
Deutsche Bank Remains a Buy on IQVIA Holdings (IQV) - The Globe and Mail
Stifel Nicolaus Maintains Buy Rating on IQVIA Holdings with $234 Price Target - AInvest
Price Channel Expanding on IQVIA Holdings Inc.’s ChartTop Performing Stock Insights Released Daily - metal.it
Fiserv Q2 Earnings Beat Estimates on Strong Margins, Revenues Miss - The Globe and Mail
5 Revealing Analyst Questions From IQVIA’s Q2 Earnings Call - Yahoo Finance
How strong is IQVIA Holdings Inc. company’s balance sheetBest Dividend Report With High Returns - jammulinksnews.com
Why IQVIA Holdings Inc. stock attracts strong analyst attentionTop Performing Stock Insights Released Daily - beatles.ru
IQVIA’s SWOT analysis: healthcare giant faces mixed outlook amid industry shifts - Investing.com Australia
IQVIA (IQV) Reliance on International Sales: What Investors Need to Know - Yahoo Finance
IQVIA Holdings Inc.'s (NYSE:IQV) P/E Is Still On The Mark Following 26% Share Price Bounce - 富途牛牛
IQVIA Holdings' Q2 2025 Earnings: Revenue Up 5.3%, EPS Down 27% - AInvest
IQVIA Holdings Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Two Large-Cap Stocks to Sell: Take-Two (TTWO) and IQVIA (IQV), One Large-Cap Stock to Watch: Zscaler (ZS) - AInvest
Finanzdaten der Iqvia Holdings Inc-Aktie (IQV)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.53%
1.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):